Global Pharmaceutical Company Implements Remote Clinician Ratings with Signant SmartSignals eClinRO Date Published: Sep 12, 2022 Case Study A global pharmaceutical company needed to implement remote clinician ratings in a multinational Alzheimer’s disease study due to movement restrictions caused by the COVID-19 pandemic. The company selected our Signant SmartSignals eClinRO solution to help: Adapt and migrate ClinRO assessments to an electronic format Ensure video ratings were performed in a way that standardized administration and scoring techniques Equip home nurses with telemedicine technology to facilitate at-home assessments Download the case study below and visit our Electronic Clinician Ratings page for more information. Learn More Share: LinkedInTweet Recommended Resources Electronic Clinician Ratings Solution Download Now Brochure Video Four Pillars for eCOA Success Whether you are conducting early-phase, local research or pivotal multinational trials, an effective electronic clinical outcome assessment (eCOA) solution helps... Watch Now Remote Alzheimer’s Disease Studies During COVID-19 Download Now Whitepaper